Glendon E. French III - 15 Sep 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol
LUNG
Transactions as of
15 Sep 2022
Net transactions value
-$500,000
Form type
4
Filing time
19 Sep 2022, 17:23:23 UTC
Previous filing
06 Sep 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $500,000 -25,000 -2.4% $20.00 1,027,944 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.